Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Epigenetics & Chromatin|August 23, 2019
The DNA repair protein SHPRH is a nucleosome-stimulated ATPase and a nucleosome-E3 ubiquitin ligaseJoanna Brühl, Jonathan Trautwein, Agnes Schäfer, et al.Brain Sciences|February 25, 2023
Identification of Dysregulated microRNAs in Glioblastoma Stem-like CellsLara Evers, Agnes Schäfer, Raffaella Pini, et al.Current Medical Science|December 21, 2022
MicroRNA-149 Regulates Proliferation, Migration, and Invasion of Pituitary Adenoma Cells by Targeting ADAM12 and MMP14Zhuo Zhang, Agnes Schäfer, Benjamin Voellger, et al.International Journal of Molecular Sciences|January 11, 2022
Inhibition of Carbonic Anhydrase 2 Overcomes Temozolomide Resistance in Glioblastoma CellsKai Zhao, Agnes Schäfer, Zhuo Zhang, et al.Cancer Cell International|March 18, 2023
Changes in calpain-2 expression during glioblastoma progression predisposes tumor cells to temozolomide resistance by minimizing DNA damage and p53-dependent apoptosisMaren Nicole Stillger, Chia-Yi Chen, Zon Weng Lai, et al.Frontiers in Cell and Developmental Biology|August 9, 2021
Extracellular Vesicle-Based Detection of Pancreatic CancerYesim Verel-Yilmaz, Juan Pablo Fernández, Agnes Schäfer, et al.Frontiers in Oncology|April 4, 2022
The Metalloprotease-Disintegrin ADAM8 Alters the Tumor Suppressor miR-181a-5p Expression Profile in Glioblastoma Thereby Contributing to Its AggressivenessAgnes Schäfer, Lara Evers, Lara Meier, et al.Journal of Clinical Medicine|September 23, 2018
The Combination of MiRNA-196b, LCN2, and TIMP1 is a Potential Set of Circulating Biomarkers for Screening Individuals at Risk for Familial Pancreatic CancerDetlef K Bartsch, Norman Gercke, Konstantin Strauch, et al.Neuro-Oncology|October 26, 2023
Proteometabolomics of initial and recurrent glioblastoma highlights an increased immune cell signature with altered lipid metabolismMiguel Cosenza-Contreras, Agnes Schäfer, Justin Sing, et al.Pageof 1